Ulcer News and Research

RSS

Twenty-five million Americans suffer from ulcers. An ulcer is a sore or hole in the lining of the stomach or duodenum (the first part of the small intestine). People of any age can get an ulcer and women are affected just as often as men.

Helicobacter pylori (H. pylori) is a bacterium that lives on the lining of the stomach. Although we used to think that spicy food, acid, and stress were the major causes of ulcers, we now know that nine out of ten ulcers are caused by H. pylori. Medicines that reduce stomach acid may make you feel better, but your ulcer may come back. Here's the good news: Since most ulcers are caused by this bacterial infection, they can be cured with the right antibiotics.

Researchers find low adherence of physicians to H. pylori guidelines

It was long thought that gastric ulcers and other digestive woes were brought about by stress. But in 2005, clinical fellow Barry J. Marshall and pathologist J. Robin Warren were awarded the Nobel Prize in Physiology or Medicine for recognizing the role of Helicobacter pylori in gastritis and peptic ulcer disease.

15 Jun 2017

Infantile spasms and multiple sclerosis relapse data presented at AAN

Mallinckrodt plc, a specialty pharmaceutical company, announced new results from two company-sponsored studies: one study on use of H.P. Acthar® Gel (repository corticotropin injection) in patients with infantile spasms (IS) and a second study on the economic burden of moderate-to-severe multiple sclerosis (MS) relapse.

2 May 2017

Isobar Compression receives SBRI research contract to advance treatment for venous leg ulcers

Isobar Compression, the world’s only exact-fit compression garment, has been awarded a research contract from the Small Business Research Initiative for Healthcare, to assist in a feasibly study in primary care for the treatment of venous leg ulcers.

26 Apr 2017

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.

26 Apr 2017

WHO marching toward extraordinary progress against neglected tropical diseases, report reveals

Since 2007, the World Health Organization (WHO) has been reporting outstanding success in dealing with neglected tropical diseases (NTDs) with 1 billion people estimated to have received treatments in 2015.

19 Apr 2017

Study compares burden of adverse events in patients implanted with HeartMate 3 and Heartmate II

A six-month analysis of the pivotal MOMENTUM 3 trial found that patients implanted with the new HeartMate 3 left ventricular assist system (LVAS) had fewer adverse clotting and bleeding events than patients implanted with the control, HeartMate II LVAS.

7 Apr 2017

Improved primary care may help reduce hospital readmissions for diabetes patients

PEOPLE who regularly visit their family doctor following discharge for a diabetes-related hospitalisation significantly reduce their chance of being readmitted, an Australian study has found

7 Mar 2017

Diagnosing Infections Through Molecules in Patient Breath

Over the past couple of decades, the analytical technology and the clinical microbiology insight needed to create a breath test for infections has seen a considerable number of advances and there are now numerous research teams focused on evaluating patient breath as a diagnostic fluid for infectious diseases. Significant challenges still need to be overcome.

From Pittcon 27 Feb 2017

FDA-approved, bioengineered living-cell therapy can shift genomic profile of non-healing wounds

Apligraf - an FDA-approved, bioengineered living-cell therapy from Organogenesis Inc. - has become the first wound-healing therapy to demonstrate a significant change in the genomic profile of a treated non-healing wound, according to new research published in the peer-reviewed journal Science Translational Medicine.

6 Jan 2017

Hospitals eliminate bedsore occurrence using early detection technology

Using technology adapted from NASA's Mars lander as part of a large-scale bedsore reduction program, over half of the 13 participating hospitals were able to eliminate the occurrence of new bedsores completely; an additional 3 hospitals achieved reductions ranging from 11% to 90%.

23 Dec 2016

Reductions in pressure injury prevalence linked to improved preventive practices

Rates of new pressure injuries in U.S. hospitals and other acute care settings have decreased by about half over the past decade, according to national survey data reported in the Journal of Wound, Ostomy and Continence Nursing.

16 Dec 2016

Mouth cancer rates increase by 68% in the UK over last two decades

A NEW Cancer Research UK analysis reveals that rates of mouth (oral) cancer have jumped by 68 per cent in the UK over the last 20 years, today (Friday).

24 Nov 2016

Revitalise introduces ‘Keep Moving’ initiative to minimise risk of pressure injury

The national disabled people’s charity Revitalise has thrown its weight behind the campaign to eradicate pressure injury with a raft of initiatives for the disabled guests at its three accessible UK holiday centres.

18 Nov 2016

New intelligent, adaptive mattress prevents and treats decubitus ulcers

Some 400,000 people in Germany each year suffer from painful pressure sores on the skin, known as decubitus ulcers. These sores primarily affect bedridden patients who cannot be sufficiently mobilized, or whose position cannot be changed frequently enough.

16 Nov 2016

Rober to exhibit full range of pioneering mattress solutions at MEDICA 2016

A UK company, who specialises in the development and manufacture of ‘zero pressure’ technology will be at MEDICA 2016 to showcase their full range of pioneering mattress solutions.

10 Nov 2016

Gas-filled balloon capsules provide new low risk treatment option for patients with obesity

Patients with obesity who swallowed gas-filled balloon capsules designed to help them eat less, lost 1.9 times more weight than patients who relied on diet, exercise and lifestyle therapy alone, according to new research presented today at ObesityWeek 2016, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity.

7 Nov 2016

Ulcer News and Research

Researchers find low adherence of physicians to H. pylori guidelines

Infantile spasms and multiple sclerosis relapse data presented at AAN

Isobar Compression receives SBRI research contract to advance treatment for venous leg ulcers

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

WHO marching toward extraordinary progress against neglected tropical diseases, report reveals

Study compares burden of adverse events in patients implanted with HeartMate 3 and Heartmate II

Improved primary care may help reduce hospital readmissions for diabetes patients

Diagnosing Infections Through Molecules in Patient Breath

FDA-approved, bioengineered living-cell therapy can shift genomic profile of non-healing wounds

Hospitals eliminate bedsore occurrence using early detection technology

Reductions in pressure injury prevalence linked to improved preventive practices

Mouth cancer rates increase by 68% in the UK over last two decades

Revitalise introduces ‘Keep Moving’ initiative to minimise risk of pressure injury

New intelligent, adaptive mattress prevents and treats decubitus ulcers

Rober to exhibit full range of pioneering mattress solutions at MEDICA 2016

Gas-filled balloon capsules provide new low risk treatment option for patients with obesity

NIH researchers identify novel role for Hsp60 protein in tissue regeneration and wound healing

Better treatment for diabetic foot disease could save billions for Australia, finds QUT research

Fungal communities in chronic wounds can be linked to poor outcomes and slow healing

Solution made of silver nanoparticles shows promise in healing diabetic foot ulcers

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News